INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
335,571
Share change
-308,855
Total reported value
$7,148,000
Price per share
$21.27
Number of holders
17
Value change
-$6,794,340
Number of buys
7
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q2 2022

As of 30 Jun 2022, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 335,571 shares. The largest 10 holders included CITADEL ADVISORS LLC, Raymond James Financial Services Advisors, Inc., FLOW TRADERS U.S. LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RAYMOND JAMES & ASSOCIATES, JANE STREET GROUP, LLC, BANK OF AMERICA CORP /DE/, Lake Point Wealth Management, ADVISOR GROUP HOLDINGS, INC., and Capstone Triton Financial Group, LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.